Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma
NCT00445068
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
LBH589
Sponsor
Novartis Pharmaceuticals